Literature DB >> 9489873

Surgery for pulmonary aspergillosis.

A Csekeo1, L Agócs, M Egerváry, Z Heiler.   

Abstract

OBJECTIVE: Surgery of pulmonary aspergillosis followed by higher incidence of post-operative complications. This was the purpose to evaluate our material.
METHODS: Between January 1983 and December 1995, the operation was carried out on a total of 84 patients for pulmonary aspergillosis. The patients were comprised of 71 males and 13 females, with a mean age of 49 years (range, 24-71). Previous lung disorders were observed in about half of the cases (most frequently tuberculosis), while in the other half aspergillosis was developed on the basis of (sub)-acute infections. Haemoptysis was present in 48% of patients. The diagnosis was suspected in 47 cases by chest X-ray. Aspergilloma was diagnosed in 50 patients pre-operatively (excluding 12 typical aspergillomas for cavernostomies), with the other pre-operative diagnoses being tuberculosis, lung cancer, pyoscelrosis, etc.
RESULTS: In 71 cases pulmonary resection was carried out (52 lobectomies, 13 wedge resections and six pulmonectomies). A total of 12 cavities were opened by cavernostomy and one lung biopsy was performed for disseminated lung disease. The post-operative mortality rate was 9.5%. The most common complications were bleeding, empyema, bronchial fistula and wound infection. In 23 patients with developed prolonged air leak and/or residual air space, complications were observed more frequently in patients with greater cavitation near the chest wall.
CONCLUSIONS: In most cases of pulmonary aspergilloma surgical intervention remains the only effective therapy. The operation has a lower risk factor in asymptomatic patients and in patients without pleural or chest wall involvement. In some cases, cavernostomy may be the only remaining surgical choice.

Entities:  

Mesh:

Year:  1997        PMID: 9489873     DOI: 10.1016/s1010-7940(97)00272-8

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  12 in total

Review 1.  The anticipation and management of air leaks and residual spaces post lung resection.

Authors:  Michael Rolf Mueller; Beatrice A Marzluf
Journal:  J Thorac Dis       Date:  2014-03       Impact factor: 2.895

2.  Is video-assisted thoracic surgery a versatile treatment for both simple and complex pulmonary aspergilloma?

Authors:  Ping Yuan; Zhitian Wang; Feichao Bao; Yunhai Yang; Jian Hu
Journal:  J Thorac Dis       Date:  2014-02       Impact factor: 2.895

Review 3.  Aspergillus fumigatus and aspergillosis.

Authors:  J P Latgé
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

Review 4.  Current strategies in the treatment of invasive Aspergillus infections in immunocompromised patients.

Authors:  S Harari
Journal:  Drugs       Date:  1999-10       Impact factor: 9.546

5.  Predictors of postoperative complications after radical resection for pulmonary aspergillosis.

Authors:  Shunsuke Endo; Shin-ichi Otani; Yasuhiro Tezuka; Kenji Tetsuka; Hiroyoshi Tsubochi; Tsuyoshi Hasegawa; Yukio Sato; Yasunori Sohara
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

6.  Surgical treatment for pulmonary aspergilloma: a 35-year experience in the Chinese population.

Authors:  Qian-Kun Chen; Ge-Ning Jiang; Jia-An Ding
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-04-11

7.  Surgery of pulmonary aspergillomas in immunocompromised patients.

Authors:  B Kosan; V Steger; T Walker; G Friedel; H Aebert
Journal:  Thorac Surg Sci       Date:  2010-03-10

8.  Lung resection in pulmonary aspergilloma: experience of a Moroccan center.

Authors:  Mohammed Massine El Hammoumi; Omar Slaoui; Fayçal El Oueriachi; El Hassane Kabiri
Journal:  BMC Surg       Date:  2015-10-16       Impact factor: 2.102

9.  Surgical Outcome of Chronic Pulmonary Aspergilloma: An Experience from Two Tertiary Referral Hospitals in Addis Ababa, Ethiopia.

Authors:  Berhanu N Alemu
Journal:  Ethiop J Health Sci       Date:  2020-07-01

10.  Results of surgery for chronic pulmonary Aspergillosis, optimal antifungal therapy and proposed high risk factors for recurrence--a National Centre's experience.

Authors:  Shakil Farid; Shaza Mohamed; Mohan Devbhandari; Matthew Kneale; Malcolm Richardson; Sing Y Soon; Mark T Jones; Piotr Krysiak; Rajesh Shah; David W Denning; Kandadai Rammohan
Journal:  J Cardiothorac Surg       Date:  2013-08-05       Impact factor: 1.637

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.